Prospective randomized open-label multicenter phase I/II dose escalation trial of visilizumab (HuM291) in severe steroid-refractory ulcerative colitis (Q33497983)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Prospective randomized open-label multicenter phase I/II dose escalation trial of visilizumab (HuM291) in severe steroid-refractory ulcerative colitis |
scientific article |
Statements
1 reference
Prospective randomized open-label multicenter phase I/II dose escalation trial of visilizumab (HuM291) in severe steroid-refractory ulcerative colitis (English)
1 reference
William J Sandborn
1 reference
Stephan R Targan
1 reference
Walter Reinisch
1 reference
Stephen B Hanauer
1 reference
Axel U Dignass
1 reference
Daniel C Baumgart
1 reference
Scott E Plevy
1 reference
Bruce A Salzberg
1 reference
Uma Mahadevan
1 reference
James N Lowder
1 reference
Matthew B Frankel
1 reference
Lloyd Mayer
1 reference
Gert van Assche
1 reference
Daan W Hommes
1 reference
Alan L Buchman
1 reference
Grigor M Mechkov
1 reference
Zahariy A Krastev
1 reference
1 April 2010
1 reference
1 reference
16
1 reference
620-629
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference